Work

Clinical impact potential of Rejuveinix (RJX) for prevention of fatal acute respiratory distress syndrome (ARDS) and multi-organ failure in COVID-19 patients.

Year: 2020

Type: article

Source: Clinical Investigation

DOI: 10.37532/2041-6792.2020.10(2).167

Authors: Fatih M. Uckun, Jim Ervin, Kazım Şahin, Joy Powell, Natalie M. Pizzimenti, Jackie Earabino, Hendrik van Wyk, Mariette van Wyk, Peter Pacult, Taha Koray Şahin, Kristina Cabala

Language: English

Topic: Respiratory Support and Mechanisms

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3037925005

FWCI: 0.705

Cites:

Cited by: 5

Related to: 10